Fajardo, Erica .

HRN: 06-25-16  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/02/2024
CEFUROXIME 500MG (TAB)
03/02/2024
03/09/2024
PO
500mg
BID
Acute Pyelonephritis
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes